Pulike Biological Engineering Inc
SSE:603566
Pulike Biological Engineering Inc
Gross Profit
Pulike Biological Engineering Inc
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Pulike Biological Engineering Inc
SSE:603566
|
Gross Profit
¥656.4m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Gross Profit
¥9.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Gross Profit
¥4.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
15%
|
CAGR 10-Years
21%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Gross Profit
¥22.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
14%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Gross Profit
¥10.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Gross Profit
¥849.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Pulike Biological Engineering Inc
Glance View
Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.
See Also
What is Pulike Biological Engineering Inc's Gross Profit?
Gross Profit
656.4m
CNY
Based on the financial report for Sep 30, 2024, Pulike Biological Engineering Inc's Gross Profit amounts to 656.4m CNY.
What is Pulike Biological Engineering Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
10%
Over the last year, the Gross Profit growth was -19%. The average annual Gross Profit growth rates for Pulike Biological Engineering Inc have been -3% over the past three years , 10% over the past five years .
You don't have any saved screeners yet